• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine.

作者信息

Arasaradnam Ramesh P, Wicaksono Alfian, O'Brien Harrison, Kocher Hemant M, Covington James A, Crnogorac-Jurcevic Tatjana

机构信息

Department of Gastroenterology, University Hospital Coventry & Warwick, Applied Biological Sciences, University of Coventry, Coventry, UK.

School of Engineering and Medical School, University of Warwick, Warwick, UK.

出版信息

Gastroenterology. 2018 Feb;154(3):485-487.e1. doi: 10.1053/j.gastro.2017.09.054. Epub 2017 Nov 10.

DOI:10.1053/j.gastro.2017.09.054
PMID:29129714
Abstract
摘要

相似文献

1
Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine.通过检测尿液中的挥发性有机化合物对胰腺癌进行无创诊断。
Gastroenterology. 2018 Feb;154(3):485-487.e1. doi: 10.1053/j.gastro.2017.09.054. Epub 2017 Nov 10.
2
Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis.通过尿液挥发性有机化合物分析检测胰腺癌
Anticancer Res. 2019 Jan;39(1):73-79. doi: 10.21873/anticanres.13081.
3
A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.尿生物标志物组合和 PancRISK 评分用于早期检测胰腺癌：一项病例对照研究。
PLoS Med. 2020 Dec 10;17(12):e1003489. doi: 10.1371/journal.pmed.1003489. eCollection 2020 Dec.
4
Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air.肺泡气中挥发性有机化合物（VOCs）分析可检测胰腺导管腺癌。
BMC Cancer. 2018 May 4;18(1):529. doi: 10.1186/s12885-018-4452-0.
5
Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients.开发 PancRISK，一种基于尿液生物标志物的风险评分，用于胰腺癌患者的分层筛查。
Br J Cancer. 2020 Mar;122(5):692-696. doi: 10.1038/s41416-019-0694-0. Epub 2019 Dec 20.
6
A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.用于胰腺导管腺癌检测的独特尿代谢组学特征。
Int J Cancer. 2021 Mar 15;148(6):1508-1518. doi: 10.1002/ijc.33368. Epub 2020 Nov 12.
7
Urine metallomics signature as an indicator of pancreatic cancer.尿液金属组学特征作为胰腺癌的标志物。
Metallomics. 2020 May 27;12(5):752-757. doi: 10.1039/d0mt00061b.
8
Urine test can detect early stage pancreatic cancer.尿液检测可以检测出早期胰腺癌。
Lancet Oncol. 2015 Sep;16(9):e431. doi: 10.1016/S1470-2045(15)00213-2. Epub 2015 Aug 6.
9
Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.胰腺导管腺癌与独特的尿代谢组学特征相关。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S415-23. doi: 10.1245/s10434-012-2686-7. Epub 2012 Oct 25.
10
Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.探索性研究：利用尿液中的挥发性有机化合物检测肝细胞癌。
Molecules. 2021 Apr 22;26(9):2447. doi: 10.3390/molecules26092447.

引用本文的文献

1
Innovative Approaches to Early Detection of Cancer-Transforming Screening for Breast, Lung, and Hard-to-Screen Cancers.癌症早期检测的创新方法——乳腺癌、肺癌及难筛查癌症的转化性筛查
Cancers (Basel). 2025 Jun 2;17(11):1867. doi: 10.3390/cancers17111867.
2
Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research.新发糖尿病与胰腺癌研究的当前范式及未来展望
Front Pharmacol. 2025 May 23;16:1543112. doi: 10.3389/fphar.2025.1543112. eCollection 2025.
3
Potential urinary volatile organic compounds as screening markers in cancer - a review.
潜在的尿液挥发性有机化合物作为癌症筛查标志物——综述
Front Oncol. 2024 Nov 25;14:1448760. doi: 10.3389/fonc.2024.1448760. eCollection 2024.
4
A Comprehensive Review of Biomarker Sensors for a Breathalyzer Platform.用于呼气分析仪平台的生物标志物传感器的全面综述。
Sensors (Basel). 2024 Nov 13;24(22):7263. doi: 10.3390/s24227263.
5
The human volatilome meets cancer diagnostics: past, present, and future of noninvasive applications.人类挥发物组分析技术在癌症诊断中的应用：非侵入性应用的过去、现在和未来。
Metabolomics. 2024 Oct 7;20(5):113. doi: 10.1007/s11306-024-02180-5.
6
Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma.表达 IL-10R2/IL-22R1 的肿瘤相关髓系细胞作为胰腺导管腺癌诊断和复发的潜在生物标志物。
Br J Cancer. 2024 Jun;130(12):1979-1989. doi: 10.1038/s41416-024-02676-w. Epub 2024 Apr 20.
7
Diagnosis of Carcinogenic Pathologies through Breath Biomarkers: Present and Future Trends.通过呼吸生物标志物诊断致癌病理：现状与未来趋势
Biomedicines. 2023 Nov 11;11(11):3029. doi: 10.3390/biomedicines11113029.
8
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers.一项系统评价与荟萃分析：挥发性有机化合物分析在肝胆胰癌检测中的应用
Cancers (Basel). 2023 Apr 14;15(8):2308. doi: 10.3390/cancers15082308.
9
Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach.慢性胰腺炎中的胰腺癌：发病机制与诊断方法
Cancers (Basel). 2023 Jan 26;15(3):761. doi: 10.3390/cancers15030761.
10
Detection of spontaneous preterm birth by maternal urinary volatile organic compound analysis: A prospective cohort study.通过母体尿液挥发性有机化合物分析检测自发性早产：一项前瞻性队列研究。
Front Pediatr. 2022 Dec 12;10:1063248. doi: 10.3389/fped.2022.1063248. eCollection 2022.